PharmaShots | Incisive News in 3 Shots

Subscribe Now

ONO Pharmaceutical

Ono Pharmaceutical Reports the EMA’s Acceptance of MAA for Vimseltinib to Treat Tenosynovial Giant Cell Tumor (TGCT)

Ono Pharmaceutical Reports the EMA’s Acceptance of MAA for Vimseltinib to Treat Tenosynovial Giant Cell Tumor (TGCT)

July 19, 2024

ONO Pharmaceutical Reports Acquisition of Deciphera Pharmaceuticals for $2.4B

ONO Pharmaceutical Reports Acquisition of Deciphera Pharmaceuticals for $2.4B

April 30, 2024

Ono Pharmaceutical and InveniAI Collaborate to Identify Novel Therapeutic Targets Using Artificial Intelligence (AI) and Machine Learning (ML)

Ono Pharmaceutical and InveniAI Collaborate to Identify Novel Therapeutic Targets Using Artificial Intelligence (AI) and Machine L...

February 20, 2024

Ono Pharmaceutical and Shattuck Labs Collaborate to Develop Bifunctional Fusion Proteins for Treating Autoimmune and Inflammatory Diseases

Ono Pharmaceutical and Shattuck Labs Collaborate to Develop Bifunctional Fusion Proteins for Treating Autoimmune and Inflammatory...

February 15, 2024

Ono Pharmaceutical’s Opdivo (nivolumab) + Yervoy (ipilimumab) Receives the MFDS Approval as 1L Treatment of Esophageal Squamous Cell Carcinoma in South Korea

Ono Pharmaceutical’s Opdivo (nivolumab) + Yervoy (ipilimumab) Receives the MFDS Approval as 1L Treatment of Esophageal Squamous Ce...

March 23, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us